ACCURUN A365 Series 200 West Nile Virus RNA Positive Control

ACCURUN 365 Series 200 West Nile Virus RNA Positive Control is designed for use with in vitro diagnostic assay procedures for the purpose of monitoring test performance. ACCURUN 365 Series 200 West Nile Virus RNA Positive Control is prepared by diluting a cultured stock of intact WNV, Lineage 1 (WNV-NY2001-6263) in WNV RNA negative defibrinated human plasma that is tested and found nonreactive for HBsAg and negative for antibodies to HIV 1 and 2, HCV and HTLV. The WNV stock was isolated from an encephalitis patient and amplified in cell culture. The culture derived virus was heat treated at 60° for 2 hours. The effectiveness of the heat treatment in inactivating virus was confirmed by using cell culture. ACCURUN controls do not have assigned values. Specific levels of reactivity will vary among different manufacturers’ assays, different procedures, different lot numbers, and different laboratories.